SecBot SecBot
DEFA14A ·Filed May 4, 2026

ABEO

ABEONA THERAPEUTICS INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001493152-26-021127
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for the definitive proxy statement (DEF 14A) or subsequent filings for material proposals such as director elections or compensation votes. The board appointment suggests governance focus, but no immediate trading catalyst.

DirectionNeutral
Confidencelow
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$5.83
T+0 close · May 4, 2026 · via day close
Latest settled
+10.98%
T+60 · $6.47
Vs SPY
+8.24%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $5.83entry
  2. T+1 · 7mo ago +3.09%α +1.70% · $6.01
  3. T+5 · 6mo ago −2.57%α −4.56% · $5.68
  4. T+20 · 6mo ago −2.40%α −7.36% · $5.69
  5. T+60 · 4mo ago +10.98%α +8.24% · $6.47

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Abeona Therapeutics filed additional definitive proxy soliciting materials (DEFA14A) on May 4, 2026, likely supplementing its proxy statement for the upcoming annual meeting. The filing content is predominantly encoded images and cannot be parsed for specific proposals, making the analysis uncertain.

Key Facts

  • Form DEFA14A filed on May 4, 2026, as additional definitive proxy soliciting materials.
  • Filing content is largely unreadable (encoded graphics), preventing extraction of specific proposals or votes.
  • Cross-filing context: an 8-K on April 7, 2026, appointed Keith A. Goldan to the Board and as Audit Committee Chair.

Financial Impact

Not specified

Risk Factors

  • Uncertainty due to unreadable filing content
  • Potential shareholder proposals or contested matters not visible

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001493152-26-021127
Document: 0001493152-26-021127-index-headers.html0001493152-26-021127
Document: 0001493152-26-021127-index.html0001493152-26-021127
Document: 0001493152-26-021127.txt0001493152-26-021127

Track record

29 reports on ABEO

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 4/10 Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
  3. Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
  4. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  5. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
  6. Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
  7. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
  8. Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
  9. Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
  10. Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Wed (9h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026